{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:42:58Z","timestamp":1788212578673,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":135,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031803956","type":"print"},{"value":"9783031803963","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-80396-3_7","type":"book-chapter","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:00:07Z","timestamp":1742356807000},"page":"183-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hereditary Medullary Thyroid Cancer: Genotype\u2013Phenotype Correlation"],"prefix":"10.1007","author":[{"given":"Karin","family":"Frank-Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"7\u20138","key":"7_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1515\/jpem.2011.262","volume":"24","author":"G Altarescu","year":"2011","unstructured":"Altarescu G, Barenholz O, Renbaum P, Beeri R, Levy-Lahad E, Margalioth EJ et al (2011) Preimplantation genetic diagnosis (PGD)\u2014prevention of the birth of children affected with endocrine diseases. J Pediatr Endocrinol Metab 24(7\u20138):543\u2013548. https:\/\/doi.org\/10.1515\/jpem.2011.262","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"7_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19(6):565\u2013612. https:\/\/doi.org\/10.1089\/thy.2008.0403","journal-title":"Thyroid"},{"issue":"4","key":"7_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1440-1827.2006.01942.x","volume":"56","author":"N Asai","year":"2006","unstructured":"Asai N, Jijiwa M, Enomoto A, Kawai K, Maeda K, Ichiahara M et al (2006) RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung\u2019s disease. Pathol Int 56(4):164\u2013172. https:\/\/doi.org\/10.1111\/j.1440-1827.2006.01942.x","journal-title":"Pathol Int"},{"issue":"3","key":"7_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1210\/jcem.83.3.4619","volume":"83","author":"I Berndt","year":"1998","unstructured":"Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M et al (1998) A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83(3):770\u2013774. https:\/\/doi.org\/10.1210\/jcem.83.3.4619","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.14310\/horm.2002.1111011","volume":"6","author":"S Bethanis","year":"2007","unstructured":"Bethanis S, Koutsodontis G, Palouka T, Avgoustis C, Yannoukakos D, Bei T et al (2007) A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A. Hormones (Athens) 6(2):152\u2013156. https:\/\/doi.org\/10.14310\/horm.2002.1111011","journal-title":"Hormones (Athens)"},{"issue":"6","key":"7_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/00000478-199106000-00009","volume":"15","author":"PW Biddinger","year":"1991","unstructured":"Biddinger PW, Brennan MF, Rosen PP (1991) Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Am J Surg Pathol 15(6):599\u2013604. https:\/\/doi.org\/10.1097\/00000478-199106000-00009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"7_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cancers16030494","volume":"16","author":"T Binter","year":"2024","unstructured":"Binter T, Baumgartner-Parzer S, Schernthaner-Reiter MH, Arikan M, Hargitai L, Niederle MB et al (2024) Does genotype-specific phenotype in patients with multiple endocrine neoplasia type 2 occur as current guidelines predict? Cancers (Basel) 16(3):494. https:\/\/doi.org\/10.3390\/cancers16030494","journal-title":"Cancers (Basel)"},{"issue":"12","key":"7_CR8","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658\u20135671. https:\/\/doi.org\/10.1210\/jcem.86.12.8070","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","volume":"144","author":"M Brauckhoff","year":"2008","unstructured":"Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K et al (2008) Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis. Surgery 144(6):1044\u20131050; discussion 1050-1043. https:\/\/doi.org\/10.1016\/j.surg.2008.08.028","journal-title":"Surgery"},{"issue":"4","key":"7_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","volume":"259","author":"M Brauckhoff","year":"2014","unstructured":"Brauckhoff M, Machens A, Lorenz K, Bjoro T, Varhaug JE, Dralle H (2014) Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective. Ann Surg 259(4):800\u2013806. https:\/\/doi.org\/10.1097\/SLA.0b013e3182a6f43a","journal-title":"Ann Surg"},{"issue":"8","key":"7_CR11","doi-asserted-by":"publisher","first-page":"T65","DOI":"10.1530\/ERC-19-0454","volume":"27","author":"P Brock","year":"2020","unstructured":"Brock P, Geurts JL, Van Galen P, Blouch E, Welch J, Kunz A et al (2020) HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes. Endocr Relat Cancer 27(8):T65\u2013T75. https:\/\/doi.org\/10.1530\/ERC-19-0454","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"7_CR12","first-page":"1076","volume":"55","author":"KM Carlson","year":"1994","unstructured":"Carlson KM, Bracamontes J, Jackson CE, Clark R, Lacroix A, Wells SA Jr, Goodfellow PJ (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55(6):1076\u20131082. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7977365","journal-title":"Am J Hum Genet"},{"issue":"6","key":"7_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"Castinetti F, Qi XP, Walz MK, Maia AL, Sanso G, Peczkowska M et al (2014) Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 15(6):648\u2013655. https:\/\/doi.org\/10.1016\/S1470-2045(14)70154-8","journal-title":"Lancet Oncol"},{"issue":"4","key":"7_CR14","doi-asserted-by":"publisher","first-page":"T135","DOI":"10.1530\/ERC-15-0175","volume":"22","author":"F Castinetti","year":"2015","unstructured":"Castinetti F, Kroiss A, Kumar R, Pacak K, Taieb D (2015) 15 YEARS OF PARAGANGLIOMA: imaging and imaging-based treatment of pheochromocytoma and paraganglioma. Endocr Relat Cancer 22(4):T135\u2013T145. https:\/\/doi.org\/10.1530\/ERC-15-0175","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"7_CR15","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/ERC-17-0209","volume":"25","author":"F Castinetti","year":"2018","unstructured":"Castinetti F, Moley J, Mulligan L, Waguespack SG (2018) A comprehensive review on MEN2B. Endocr Relat Cancer 25(2):T29\u2013T39. https:\/\/doi.org\/10.1530\/ERC-17-0209","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"7_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","volume":"7","author":"F Castinetti","year":"2019","unstructured":"Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G et al (2019) Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 7(3):213\u2013220. https:\/\/doi.org\/10.1016\/S2213-8587(18)30336-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"7_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03347719","volume":"17","author":"I Ceccherini","year":"1994","unstructured":"Ceccherini I, Romei C, Barone V, Pacini F, Martino E, Loviselli A et al (1994) Identification of the Cys634\u2014>Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. J Endocrinol Investig 17(3):201\u2013204. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7914213","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"7_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/thy.2017.0200","volume":"28","author":"S Chen","year":"2018","unstructured":"Chen S, Li S, Zhang J, Zhang L, Chen Y, Wang L et al (2018) Preimplantation genetic diagnosis of multiple endocrine neoplasia type 2A using informative markers identified by targeted sequencing. Thyroid 28(3):281\u2013287. https:\/\/doi.org\/10.1089\/thy.2017.0200","journal-title":"Thyroid"},{"issue":"2","key":"7_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002420","volume":"8","author":"SK Choi","year":"2012","unstructured":"Choi SK, Yoon SR, Calabrese P, Arnheim N (2012) Positive selection for new disease mutations in the human germline: evidence from the heritable cancer syndrome multiple endocrine neoplasia type 2B. PLoS Genet 8(2):e1002420. https:\/\/doi.org\/10.1371\/journal.pgen.1002420","journal-title":"PLoS Genet"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-015-0231-z","volume":"10","author":"C Colombo","year":"2015","unstructured":"Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L et al (2015) The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression\/penetrance studies. Orphanet J Rare Dis 10:25. https:\/\/doi.org\/10.1186\/s13023-015-0231-z","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"7_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-11-0117","volume":"18","author":"B Cosci","year":"2011","unstructured":"Cosci B, Vivaldi A, Romei C, Gemignani F, Landi S, Ciampi R et al (2011) In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocr Relat Cancer 18(5):603\u2013612. https:\/\/doi.org\/10.1530\/ERC-11-0117","journal-title":"Endocr Relat Cancer"},{"issue":"20","key":"7_CR22","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1158\/0008-5472.CAN-06-0884","volume":"66","author":"AN Cranston","year":"2006","unstructured":"Cranston AN, Carniti C, Oakhill K, Radzio-Andzelm E, Stone EA, McCallion AS et al (2006) RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Res 66(20):10179\u201310187. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0884","journal-title":"Cancer Res"},{"issue":"3","key":"7_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018380","volume":"6","author":"DK Crockett","year":"2011","unstructured":"Crockett DK, Piccolo SR, Ridge PG, Margraf RL, Lyon E, Williams MS, Mitchell JA (2011) Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene. PLoS One 6(3):e18380. https:\/\/doi.org\/10.1371\/journal.pone.0018380","journal-title":"PLoS One"},{"issue":"11","key":"7_CR24","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1210\/jc.2003-030997","volume":"88","author":"AM Da Silva","year":"2003","unstructured":"Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM (2003) A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab 88(11):5438\u20135443. https:\/\/doi.org\/10.1210\/jc.2003-030997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamaoto.2022.4196","volume":"149","author":"L Davies","year":"2023","unstructured":"Davies L, Angelos P (2023) Medullary thyroid carcinoma and population screening-the promise and pitfalls of genetic testing. JAMA Otolaryngol Head Neck Surg 149(3):202\u2013203. https:\/\/doi.org\/10.1001\/jamaoto.2022.4196","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"7_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2(7):851\u2013856. https:\/\/doi.org\/10.1093\/hmg\/2.7.851","journal-title":"Hum Mol Genet"},{"issue":"8","key":"7_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1515\/cclm-2018-1186","volume":"57","author":"F Eckelt","year":"2019","unstructured":"Eckelt F, Vogel M, Geserick M, Kirsten T, Bae YJ, Baber R et al (2019) Calcitonin measurement in pediatrics: reference ranges are gender-dependent, validation in medullary thyroid cancer and thyroid diseases. Clin Chem Lab Med 57(8):1242\u20131250. https:\/\/doi.org\/10.1515\/cclm-2018-1186","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"7_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","volume":"51","author":"G Eisenhofer","year":"2005","unstructured":"Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM et al (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51(4):735\u2013744. https:\/\/doi.org\/10.1373\/clinchem.2004.045484","journal-title":"Clin Chem"},{"issue":"11","key":"7_CR29","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1210\/jc.2004-0312","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Cosci B, Romei C, Agate L, Piampiani P, Miccoli P et al (2004) Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. J Clin Endocrinol Metab 89(11):5823\u20135827. https:\/\/doi.org\/10.1210\/jc.2004-0312","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"7_CR30","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2007-1005","volume":"92","author":"R Elisei","year":"2007","unstructured":"Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E et al (2007) RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab 92(12):4725\u20134729. https:\/\/doi.org\/10.1210\/jc.2007-1005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1210\/jc.2007-1714","volume":"93","author":"R Elisei","year":"2008","unstructured":"Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93(3):682\u2013687. https:\/\/doi.org\/10.1210\/jc.2007-1714","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/jc.2011-2046","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E et al (2012) The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab 97(2):426\u2013435. https:\/\/doi.org\/10.1210\/jc.2011-2046","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000346174","volume":"1","author":"R Elisei","year":"2013","unstructured":"Elisei R, Alevizaki M, Conte-Devolx B, Frank-Raue K, Leite V, Williams GR (2013) 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J 1(4):216\u2013231. https:\/\/doi.org\/10.1159\/000346174","journal-title":"Eur Thyroid J"},{"issue":"9","key":"7_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/genes10090698","volume":"10","author":"R Elisei","year":"2019","unstructured":"Elisei R, Tacito A, Ramone T, Ciampi R, Bottici V, Cappagli V et al (2019) Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations. Genes (Basel) 10(9):698. https:\/\/doi.org\/10.3390\/genes10090698","journal-title":"Genes (Basel)"},{"issue":"19","key":"7_CR35","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF et al (1996a) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276(19):1575\u20131579. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8918855","journal-title":"JAMA"},{"issue":"9","key":"7_CR36","first-page":"2167","volume":"56","author":"C Eng","year":"1996","unstructured":"Eng C, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F et al (1996b) Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res 56(9):2167\u20132170. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8616867","journal-title":"Cancer Res"},{"issue":"1","key":"7_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/jc.2009-1728","volume":"95","author":"Z Erlic","year":"2010","unstructured":"Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I et al (2010) Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. J Clin Endocrinol Metab 95(1):308\u2013313. https:\/\/doi.org\/10.1210\/jc.2009-1728","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7_CR38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.5858\/132.11.1767","volume":"132","author":"D Etit","year":"2008","unstructured":"Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ (2008) Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med 132(11):1767\u20131773. https:\/\/doi.org\/10.5858\/132.11.1767","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"7_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1067\/msy.2000.107103","volume":"128","author":"GL Feldman","year":"2000","unstructured":"Feldman GL, Edmonds MW, Ainsworth PJ, Schuffenecker I, Lenoir GM, Saxe AW et al (2000) Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG\u2014>ATG) mutation. Surgery 128(1):93\u201398. https:\/\/doi.org\/10.1067\/msy.2000.107103","journal-title":"Surgery"},{"issue":"1","key":"7_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jpedsurg.2007.09.043","volume":"43","author":"EA Fialkowski","year":"2008","unstructured":"Fialkowski EA, DeBenedetti MK, Moley JF, Bachrach B (2008) RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. J Pediatr Surg 43(1):188\u2013190. https:\/\/doi.org\/10.1016\/j.jpedsurg.2007.09.043","journal-title":"J Pediatr Surg"},{"issue":"1","key":"7_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2012.09.002","volume":"752","author":"G Figlioli","year":"2013","unstructured":"Figlioli G, Landi S, Romei C, Elisei R, Gemignani F (2013) Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res 752(1):36\u201344. https:\/\/doi.org\/10.1016\/j.mrrev.2012.09.002","journal-title":"Mutat Res"},{"issue":"5","key":"7_CR42","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1210\/jcem.81.5.8626834","volume":"81","author":"K Frank-Raue","year":"1996","unstructured":"Frank-Raue K, Hoppner W, Frilling A, Kotzerke J, Dralle H, Haase R et al (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81(5):1780\u20131783. https:\/\/doi.org\/10.1210\/jcem.81.5.8626834","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T et al (2006) Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155(2):229\u2013236. https:\/\/doi.org\/10.1530\/eje.1.02216","journal-title":"Eur J Endocrinol"},{"issue":"5\u20136","key":"7_CR44","first-page":"273","volume":"53","author":"K Frank-Raue","year":"2007","unstructured":"Frank-Raue K, Rondot S, Schulze E, Raue F (2007) Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab 53(5\u20136):273\u2013282. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17605401","journal-title":"Clin Lab"},{"issue":"2","key":"7_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03215.x","volume":"69","author":"K Frank-Raue","year":"2008","unstructured":"Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F, German MEN2 Study Group (2008) Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol 69(2):259\u2013263. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03215.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"7_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, H\u00fcfner M, Wohllk N, Opocher G, Dvo\u0159\u00e1kov\u00e1 S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorl\u00e4nder C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, W\u00fcster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP, International RET Exon 10 Consortium (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32(1):51\u201358. https:\/\/doi.org\/10.1002\/humu.21385","journal-title":"Hum Mutat"},{"issue":"6","key":"7_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/cen.14060","volume":"91","author":"JM Fussey","year":"2019","unstructured":"Fussey JM, Vaidya B, Kim D, Clark J, Ellard S, Smith JA (2019) The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: a systematic review. Clin Endocrinol 91(6):697\u2013707. https:\/\/doi.org\/10.1111\/cen.14060","journal-title":"Clin Endocrinol"},{"issue":"10","key":"7_CR48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-111-10-802","volume":"111","author":"RF Gagel","year":"1989","unstructured":"Gagel RF, Levy ML, Donovan DT, Alford BR, Wheeler T, Tschen JA (1989) Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med 111(10):802\u2013806. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2573304","journal-title":"Ann Intern Med"},{"issue":"7","key":"7_CR49","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jpedsurg.2016.10.054","volume":"52","author":"S Gfroerer","year":"2017","unstructured":"Gfroerer S, Theilen TM, Fiegel H, Harter PN, Mittelbronn M, Rolle U (2017) Identification of intestinal ganglioneuromatosis leads to early diagnosis of MEN2B: role of rectal biopsy. J Pediatr Surg 52(7):1161\u20131165. https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.10.054","journal-title":"J Pediatr Surg"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"4147097","DOI":"10.1155\/2020\/4147097","volume":"2020","author":"C Giani","year":"2020","unstructured":"Giani C, Ramone T, Romei C, Ciampi R, Tacito A, Valerio L et al (2020) A new MEN2 syndrome with clinical features of both MEN2A and MEN2B associated with a new RET germline deletion. Case Rep Endocrinol 2020:4147097. https:\/\/doi.org\/10.1155\/2020\/4147097","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"7_CR51","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1067\/msy.2002.128559","volume":"132","author":"O Gimm","year":"2002","unstructured":"Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M et al (2002) RET proto-oncogene mutations affecting codon 790\/791: a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 132(6):952\u2013959; discussion 959. https:\/\/doi.org\/10.1067\/msy.2002.128559","journal-title":"Surgery"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1196\/annals.1353.025","volume":"1073","author":"TS Gujral","year":"2006","unstructured":"Gujral TS, Mulligan LM (2006) Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2. Ann N Y Acad Sci 1073:234\u2013240. https:\/\/doi.org\/10.1196\/annals.1353.025","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"7_CR53","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cancers15072125","volume":"15","author":"M Holm","year":"2023","unstructured":"Holm M, Vestergaard P, Poulsen MM, Rasmussen AK, Feldt-Rasmussen U, Bay M et al (2023) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A in Denmark 1930\u20132021: a nationwide population-based retrospective study. Cancers (Basel) 15(7):2125. https:\/\/doi.org\/10.3390\/cancers15072125","journal-title":"Cancers (Basel)"},{"issue":"2","key":"7_CR54","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/jc.2003-031091","volume":"89","author":"I Ilias","year":"2004","unstructured":"Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479\u2013491. https:\/\/doi.org\/10.1210\/jc.2003-031091","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7_CR55","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.3390\/cancers12113268","volume":"12","author":"G Innella","year":"2020","unstructured":"Innella G, Rossi C, Romagnoli M, Repaci A, Bianchi D, Cantarini ME et al (2020) Results and clinical interpretation of germline RET analysis in a series of patients with medullary thyroid carcinoma: the challenge of the variants of uncertain significance. Cancers (Basel) 12(11):3268. https:\/\/doi.org\/10.3390\/cancers12113268","journal-title":"Cancers (Basel)"},{"issue":"4","key":"7_CR56","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1210\/jc.2017-02402","volume":"103","author":"T Jaber","year":"2018","unstructured":"Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu R (2018) A homozygous RET K666N genotype with an MEN2A phenotype. J Clin Endocrinol Metab 103(4):1269\u20131272. https:\/\/doi.org\/10.1210\/jc.2017-02402","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/thy.2010.0328","volume":"21","author":"S Jasim","year":"2011","unstructured":"Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C et al (2011) Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 21(2):189\u2013192. https:\/\/doi.org\/10.1089\/thy.2010.0328","journal-title":"Thyroid"},{"issue":"9","key":"7_CR58","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1373\/clinchem.2016.270009","volume":"63","author":"GJ Kahaly","year":"2017","unstructured":"Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S et al (2017) United States and European multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem 63(9):1489\u20131496. https:\/\/doi.org\/10.1373\/clinchem.2016.270009","journal-title":"Clin Chem"},{"issue":"5","key":"7_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2265.2006.02509.x","volume":"64","author":"P Kaldrymides","year":"2006","unstructured":"Kaldrymides P, Mytakidis N, Anagnostopoulos T, Vassiliou M, Tertipi A, Zahariou M et al (2006) A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Clin Endocrinol 64(5):561\u2013566. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02509.x","journal-title":"Clin Endocrinol"},{"issue":"29","key":"7_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001108","volume":"94","author":"WP Kluijfhout","year":"2015","unstructured":"Kluijfhout WP, van Beek DJ, Verrijn Stuart AA, Lodewijk L, Valk GD, van der Zee DC et al (2015) Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis. Medicine (Baltimore) 94(29):e1108. https:\/\/doi.org\/10.1097\/MD.0000000000001108","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"7_CR61","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s002689900123","volume":"20","author":"JL Kraimps","year":"1996","unstructured":"Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F et al (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d\u2019Etude des tumeurs a calcitonine (GETC, French calcitonin tumors study group), French Association of Endocrine Surgeons. World J Surg 20(7):808\u2013812; discussion 812-803. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8678955","journal-title":"World J Surg"},{"issue":"6","key":"7_CR62","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1210\/jc.2004-1622","volume":"90","author":"F Lesueur","year":"2005","unstructured":"Lesueur F, Cebrian A, Cranston A, Leyland J, Faid TM, Clements MR et al (2005) Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma\/multiple endocrine neoplasia type 2A patients. J Clin Endocrinol Metab 90(6):3454\u20133457. https:\/\/doi.org\/10.1210\/jc.2004-1622","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10689-016-9948-7","volume":"16","author":"KL Long","year":"2017","unstructured":"Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH et al (2017) All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer 16(2):283\u2013289. https:\/\/doi.org\/10.1007\/s10689-016-9948-7","journal-title":"Fam Cancer"},{"issue":"11","key":"7_CR64","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1210\/jc.2017-02529","volume":"103","author":"C Loveday","year":"2018","unstructured":"Loveday C, Josephs K, Chubb D, Gunning A, Izatt L, Tischkowitz M et al (2018) p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer. J Clin Endocrinol Metab 103(11):4275\u20134282. https:\/\/doi.org\/10.1210\/jc.2017-02529","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"7_CR65","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jamaoto.2023.1576","volume":"149","author":"A Machens","year":"2023","unstructured":"Machens A, Dralle H (2023) Population-based genomic RET screening. JAMA Otolaryngol Head Neck Surg 149(9):852\u2013853. https:\/\/doi.org\/10.1001\/jamaoto.2023.1576","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"7_CR66","doi-asserted-by":"publisher","first-page":"K43","DOI":"10.1093\/ejendo\/lvae025","volume":"190","author":"A Machens","year":"2024","unstructured":"Machens A, Dralle H (2024) Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. Eur J Endocrinol 190(3):K43\u2013K46. https:\/\/doi.org\/10.1093\/ejendo\/lvae025","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"7_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1067\/s0039-6060(03)00157-0","volume":"134","author":"A Machens","year":"2003","unstructured":"Machens A, Holzhausen HJ, Thanh PN, Dralle H (2003a) Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 134(3):425\u2013431. https:\/\/doi.org\/10.1067\/s0039-6060(03)00157-0","journal-title":"Surgery"},{"issue":"16","key":"7_CR68","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD et al (2003b) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349(16):1517\u20131525. https:\/\/doi.org\/10.1056\/NEJMoa012915","journal-title":"N Engl J Med"},{"issue":"2","key":"7_CR69","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","volume":"250","author":"A Machens","year":"2009","unstructured":"Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Ann Surg 250(2):305\u2013310. https:\/\/doi.org\/10.1097\/SLA.0b013e3181ae333f","journal-title":"Ann Surg"},{"issue":"3","key":"7_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-12-0919","volume":"168","author":"A Machens","year":"2013","unstructured":"Machens A, Lorenz K, Sekulla C, Hoppner W, Frank-Raue K, Raue F, Dralle H (2013) Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur J Endocrinol 168(3):307\u2013314. https:\/\/doi.org\/10.1530\/EJE-12-0919","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"7_CR71","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/bjs.10746","volume":"105","author":"A Machens","year":"2018","unstructured":"Machens A, Elwerr M, Lorenz K, Weber F, Dralle H (2018) Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations. Br J Surg 105(2):e150\u2013e157. https:\/\/doi.org\/10.1002\/bjs.10746","journal-title":"Br J Surg"},{"issue":"2","key":"7_CR72","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12020-020-02232-5","volume":"68","author":"A Machens","year":"2020","unstructured":"Machens A, Elwerr M, Lorenz K, Weber F, Dralle H (2020) 100-year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A. Endocrine 68(2):368\u2013376. https:\/\/doi.org\/10.1007\/s12020-020-02232-5","journal-title":"Endocrine"},{"issue":"1","key":"7_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12020-021-02686-1","volume":"73","author":"A Machens","year":"2021","unstructured":"Machens A, Lorenz K, Dralle H (2021) Kidney malformations and Hirschsprung\u2019s disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene. Endocrine 73(1):217\u2013222. https:\/\/doi.org\/10.1007\/s12020-021-02686-1","journal-title":"Endocrine"},{"issue":"9","key":"7_CR74","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1210\/clinem\/dgad156","volume":"108","author":"A Machens","year":"2023","unstructured":"Machens A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, Weber F, Dralle H (2023) The changing face of multiple endocrine neoplasia 2A: from symptom-based to preventative medicine. J Clin Endocrinol Metab 108(9):e734\u2013e742. https:\/\/doi.org\/10.1210\/clinem\/dgad156","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7_CR75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1530\/EC-18-0506","volume":"8","author":"RMB Maciel","year":"2019","unstructured":"Maciel RMB, Camacho CP, Assumpcao LVM, Bufalo NE, Carvalho AL, de Carvalho GA et al (2019) Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study. Endocr Connect 8(3):289\u2013298. https:\/\/doi.org\/10.1530\/EC-18-0506","journal-title":"Endocr Connect"},{"issue":"8","key":"7_CR76","doi-asserted-by":"publisher","first-page":"e238423","DOI":"10.1136\/bcr-2020-238423","volume":"13","author":"R Malhotra","year":"2020","unstructured":"Malhotra R, Boro H, Shamim SA, Khadgawat R (2020) Multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis. BMJ Case Rep 13(8):e238423. https:\/\/doi.org\/10.1136\/bcr-2020-238423","journal-title":"BMJ Case Rep"},{"issue":"12","key":"7_CR77","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/humu.24486","volume":"43","author":"RL Margraf","year":"2022","unstructured":"Margraf RL, Alexander RZ, Fulmer ML, Miller CE, Coupal E, Mao R (2022) Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG\/AMP variant classification guidelines and impact on the MEN2 RET database. Hum Mutat 43(12):1780\u20131794. https:\/\/doi.org\/10.1002\/humu.24486","journal-title":"Hum Mutat"},{"issue":"6130","key":"7_CR78","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/328527a0","volume":"328","author":"CG Mathew","year":"1987","unstructured":"Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI et al (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328(6130):527\u2013528. https:\/\/doi.org\/10.1038\/328527a0","journal-title":"Nature"},{"issue":"2","key":"7_CR79","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/thy.2019.0472","volume":"31","author":"A Mathew","year":"2021","unstructured":"Mathew A, Latteyer S, Frank-Raue K, Moeller LC, Zwanziger D, Mengel M et al (2021) A novel double RET E768D\/L790F mutation associated with a MEN2B-like phenotype. Thyroid 31(2):327\u2013329. https:\/\/doi.org\/10.1089\/thy.2019.0472","journal-title":"Thyroid"},{"issue":"6","key":"7_CR80","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1210\/jc.2016-3640","volume":"102","author":"JS Mathiesen","year":"2017","unstructured":"Mathiesen JS, Habra MA, Bassett JHD, Choudhury SM, Balasubramanian SP, Howlett TA et al (2017) Risk profile of the RET A883F germline mutation: an international collaborative study. J Clin Endocrinol Metab 102(6):2069\u20132074. https:\/\/doi.org\/10.1210\/jc.2016-3640","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7_CR81","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/EC-18-0157","volume":"7","author":"JS Mathiesen","year":"2018","unstructured":"Mathiesen JS, Kroustrup JP, Vestergaard P, Stochholm K, Poulsen PL, Rasmussen AK et al (2018) Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960\u20132014: a nationwide study. Endocr Connect 7(6):829\u2013839. https:\/\/doi.org\/10.1530\/EC-18-0157","journal-title":"Endocr Connect"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fendo.2020.00251","volume":"11","author":"JS Mathiesen","year":"2020","unstructured":"Mathiesen JS, Nielsen SG, Rasmussen AK, Kiss K, Wadt K, Hermann AP et al (2020) Variability in medullary thyroid carcinoma in RET L790F carriers: a case comparison study of index patients. Front Endocrinol (Lausanne) 11:251. https:\/\/doi.org\/10.3389\/fendo.2020.00251","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","volume":"79","author":"JS Mathiesen","year":"2022","unstructured":"Mathiesen JS, Effraimidis G, Rossing M, Rasmussen AK, Hoejberg L, Bastholt L et al (2022) Multiple endocrine neoplasia type 2: a review. Semin Cancer Biol 79:163\u2013179. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.035","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"7_CR84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/jcem.87.1.8136","volume":"87","author":"FH Menko","year":"2002","unstructured":"Menko FH, van der Luijt RB, de Valk IA, Toorians AW, Sepers JM, van Diest PJ, Lips CJ (2002) Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab 87(1):393\u2013397. https:\/\/doi.org\/10.1210\/jcem.87.1.8136","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7_CR85","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1677\/ERC-08-0105","volume":"15","author":"IN Milos","year":"2008","unstructured":"Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A et al (2008) Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Endocr Relat Cancer 15(4):1035\u20131041. https:\/\/doi.org\/10.1677\/ERC-08-0105","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"7_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.1999.tb00658.x","volume":"90","author":"A Miyauchi","year":"1999","unstructured":"Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N et al (1999) Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 90(1):1\u20135. https:\/\/doi.org\/10.1111\/j.1349-7006.1999.tb00658.x","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"7_CR87","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"Mucha L, Leidig-Bruckner G, Frank-Raue K, Bruckner T, Kroiss M, Raue F, German Study Group for Rare Thyroid Cancer (2017) Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin Endocrinol 87(4):320\u2013326. https:\/\/doi.org\/10.1111\/cen.13386","journal-title":"Clin Endocrinol"},{"issue":"8","key":"7_CR88","doi-asserted-by":"publisher","first-page":"T189","DOI":"10.1530\/ERC-18-0141","volume":"25","author":"LM Mulligan","year":"2018","unstructured":"Mulligan LM (2018) 65 YEARS OF THE DOUBLE HELIX: exploiting insights on the RET receptor for personalized cancer medicine. Endocr Relat Cancer 25(8):T189\u2013T200. https:\/\/doi.org\/10.1530\/ERC-18-0141","journal-title":"Endocr Relat Cancer"},{"issue":"6428","key":"7_CR89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363(6428):458\u2013460. https:\/\/doi.org\/10.1038\/363458a0","journal-title":"Nature"},{"issue":"7","key":"7_CR90","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/thy.2019.0785","volume":"30","author":"MB Niederle","year":"2020","unstructured":"Niederle MB, Scheuba C, Riss P, Selberherr A, Koperek O, Niederle B (2020) Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30(7):974\u2013984. https:\/\/doi.org\/10.1089\/thy.2019.0785","journal-title":"Thyroid"},{"issue":"9","key":"7_CR91","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/thy.2010.0190","volume":"21","author":"MN Oliveira","year":"2011","unstructured":"Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP et al (2011) The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. Thyroid 21(9):975\u2013985. https:\/\/doi.org\/10.1089\/thy.2010.0190","journal-title":"Thyroid"},{"issue":"2","key":"7_CR92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.14310\/horm.2002.1227","volume":"8","author":"K Pacak","year":"2009","unstructured":"Pacak K, Eisenhofer G, Ilias I (2009) Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome. Hormones (Athens) 8(2):111\u2013116. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19570738","journal-title":"Hormones (Athens)"},{"issue":"6","key":"7_CR93","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1530\/EJE-08-0476","volume":"159","author":"M Peppa","year":"2008","unstructured":"Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG et al (2008) Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene. Eur J Endocrinol 159(6):767\u2013771. https:\/\/doi.org\/10.1530\/EJE-08-0476","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"7_CR94","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaoto.2022.4195","volume":"149","author":"PFA Pichardo","year":"2023","unstructured":"Pichardo PFA, Hellums RN, Hao J, Savatt JM, Hassen D, Pellitteri PK et al (2023) Thyroidectomy outcomes in patients identified with RET pathogenic variants through a population genomic screening program. JAMA Otolaryngol Head Neck Surg 149(3):195\u2013202. https:\/\/doi.org\/10.1001\/jamaoto.2022.4195","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"32","key":"7_CR95","doi-asserted-by":"publisher","first-page":"33993","DOI":"10.18632\/oncotarget.4992","volume":"6","author":"XP Qi","year":"2015","unstructured":"Qi XP, Zhao JQ, Chen ZG, Cao JL, Du J, Liu NF et al (2015) RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D. Oncotarget 6(32):33993\u201334003. https:\/\/doi.org\/10.18632\/oncotarget.4992","journal-title":"Oncotarget"},{"issue":"9","key":"7_CR96","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1530\/EC-18-0220","volume":"7","author":"XP Qi","year":"2018","unstructured":"Qi XP, Peng JZ, Yang XW, Zao ZL, Yu XH, Fang XD et al (2018) The RET C611Y mutation causes MEN 2A and associated cutaneous. Endocr Connect 7(9):998\u20131005. https:\/\/doi.org\/10.1530\/EC-18-0220","journal-title":"Endocr Connect"},{"issue":"6","key":"7_CR97","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R, Moley JF (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142(6):800\u2013805; discussion 805.e801. https:\/\/doi.org\/10.1016\/j.surg.2007.09.013","journal-title":"Surgery"},{"issue":"Suppl 1","key":"7_CR98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6061\/clinics\/2012(Sup01)13","volume":"67 Suppl 1","author":"F Raue","year":"2012","unstructured":"Raue F, Frank-Raue K (2012) Genotype-phenotype correlation in multiple endocrine neoplasia type 2. Clinics (Sao Paulo) 67 Suppl 1(Suppl 1):69\u201375","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"7_CR99","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A et al (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238(4):369\u2013373. https:\/\/doi.org\/10.1111\/j.1365-2796.1995.tb01212.x","journal-title":"J Intern Med"},{"issue":"1","key":"7_CR100","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/jc.2017-01884","volume":"103","author":"F Raue","year":"2018","unstructured":"Raue F, Dralle H, Machens A, Bruckner T, Frank-Raue K (2018) Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium. J Clin Endocrinol Metab 103(1):235\u2013243. https:\/\/doi.org\/10.1210\/jc.2017-01884","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"7_CR101","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2019-00516","volume":"104","author":"F Raue","year":"2019","unstructured":"Raue F, Bruckner T, Frank-Raue K (2019) Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center. J Clin Endocrinol Metab 104(10):4264\u20134272. https:\/\/doi.org\/10.1210\/jc.2019-00516","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7_CR102","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1089\/thy.2013.0620","volume":"24","author":"TA Rich","year":"2014","unstructured":"Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M et al (2014a) Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid 24(7):1096\u20131106. https:\/\/doi.org\/10.1089\/thy.2013.0620","journal-title":"Thyroid"},{"issue":"2","key":"7_CR103","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10689-013-9685-0","volume":"13","author":"TA Rich","year":"2014","unstructured":"Rich TA, Liu M, Etzel CJ, Bannon SA, Mork ME, Ready K et al (2014b) Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer 13(2):291\u2013299. https:\/\/doi.org\/10.1007\/s10689-013-9685-0","journal-title":"Fam Cancer"},{"issue":"5","key":"7_CR104","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"3","key":"7_CR105","doi-asserted-by":"publisher","first-page":"E509","DOI":"10.1210\/jc.2010-1234","volume":"96","author":"V Rohmer","year":"2011","unstructured":"Rohmer V, Vidal-Trecan G, Bourdelot A, Niccoli P, Murat A, Wemeau JL et al (2011) Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d\u2019Etude des Tumeurs endocrines. J Clin Endocrinol Metab 96(3):E509\u2013E518. https:\/\/doi.org\/10.1210\/jc.2010-1234","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7_CR106","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1210\/jcem.81.4.8636377","volume":"81","author":"C Romei","year":"1996","unstructured":"Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F et al (1996) Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab 81(4):1619\u20131622. https:\/\/doi.org\/10.1210\/jcem.81.4.8636377","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7_CR107","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1089\/thy.2011-0358","volume":"22","author":"C Romei","year":"2012","unstructured":"Romei C, Ugolini C, Cosci B, Torregrossa L, Vivaldi A, Ciampi R et al (2012) Low prevalence of the somatic M918t ret mutation in micro-medullary thyroid cancer. Thyroid 22(5):476\u2013481. https:\/\/doi.org\/10.1089\/thy.2011-0358","journal-title":"Thyroid"},{"issue":"4","key":"7_CR108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrendo.2016.11","volume":"12","author":"C Romei","year":"2016","unstructured":"Romei C, Ciampi R, Elisei R (2016) A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol 12(4):192\u2013202. https:\/\/doi.org\/10.1038\/nrendo.2016.11","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"7_CR109","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/thy.2009.0021","volume":"19","author":"AE Rothberg","year":"2009","unstructured":"Rothberg AE, Raymond VM, Gruber SB, Sisson J (2009) Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis. Thyroid 19(6):651\u2013655. https:\/\/doi.org\/10.1089\/thy.2009.0021","journal-title":"Thyroid"},{"issue":"4","key":"7_CR110","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jso.23378","volume":"108","author":"KJ Rowland","year":"2013","unstructured":"Rowland KJ, Chernock RD, Moley JF (2013) Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening. J Surg Oncol 108(4):203\u2013206. https:\/\/doi.org\/10.1002\/jso.23378","journal-title":"J Surg Oncol"},{"issue":"19","key":"7_CR111","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.3390\/cancers15194865","volume":"15","author":"N Sahakian","year":"2023","unstructured":"Sahakian N, Castinetti F, Romanet P (2023) Molecular basis and natural history of medullary thyroid cancer: it is (almost) all in the RET. Cancers (Basel) 15(19):4865. https:\/\/doi.org\/10.3390\/cancers15194865","journal-title":"Cancers (Basel)"},{"issue":"5196","key":"7_CR112","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.7824936","volume":"267","author":"M Santoro","year":"1995","unstructured":"Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M et al (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267(5196):381\u2013383. https:\/\/doi.org\/10.1126\/science.7824936","journal-title":"Science"},{"issue":"6","key":"7_CR113","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1365-2265.2012.04462.x","volume":"77","author":"HL Sarika","year":"2012","unstructured":"Sarika HL, Papathoma A, Garofalaki M, Vasileiou V, Vlassopoulou B, Anastasiou E, Alevizaki M (2012) High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece. Clin Endocrinol 77(6):857\u2013862. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04462.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"7_CR114","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","volume":"15","author":"JO Scapineli","year":"2016","unstructured":"Scapineli JO, Ceolin L, Punales MK, Dora JM, Maia AL (2016) MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer 15(4):625\u2013633. https:\/\/doi.org\/10.1007\/s10689-016-9892-6","journal-title":"Fam Cancer"},{"issue":"1","key":"7_CR115","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13052-020-00901-9","volume":"46","author":"IAM Schierz","year":"2020","unstructured":"Schierz IAM, Cimador M, Giuffre M, Aiello CM, Antona V, Corsello G, Piro E (2020) Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report. Ital J Pediatr 46(1):135. https:\/\/doi.org\/10.1186\/s13052-020-00901-9","journal-title":"Ital J Pediatr"},{"issue":"1","key":"7_CR116","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/1097-0215(20010120)95:1<62::aid-ijc1011>3.0.co;2-1","volume":"95","author":"T Schilling","year":"2001","unstructured":"Schilling T, Burck J, Sinn HP, Clemens A, Otto HF, Hoppner W et al (2001) Prognostic value of codon 918 (ATG\u2014>ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer 95(1):62\u201366. https:\/\/doi.org\/10.1002\/1097-0215(20010120)95:1<62::aid-ijc1011>3.0.co;2-1","journal-title":"Int J Cancer"},{"issue":"2","key":"7_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104141","volume":"64","author":"S Schirwani","year":"2021","unstructured":"Schirwani S, Fraser S, Mushtaq T, Chengot P, Mavrogiannis LA, Jewell R, Adlard J (2021) Homozygosity for the pathogenic RET hotspot variant p.Cys634Trp: a consanguineous family with MEN2A. Eur J Med Genet 64(2):104141. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104141","journal-title":"Eur J Med Genet"},{"issue":"1","key":"7_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4158\/EP10050.OR","volume":"17","author":"A Scholten","year":"2011","unstructured":"Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel Rinkes IH (2011a) Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract 17(1):7\u201315. https:\/\/doi.org\/10.4158\/EP10050.OR","journal-title":"Endocr Pract"},{"issue":"6","key":"7_CR119","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0b013e318237480c","volume":"254","author":"A Scholten","year":"2011","unstructured":"Scholten A, Valk GD, Ulfman D, Borel Rinkes IH, Vriens MR (2011b) Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg 254(6):1022\u20131027. https:\/\/doi.org\/10.1097\/SLA.0b013e318237480c","journal-title":"Ann Surg"},{"issue":"2","key":"7_CR120","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/jcem.83.2.4529","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des tumeurs a calcitonine. J Clin Endocrinol Metab 83(2):487\u2013491. https:\/\/doi.org\/10.1210\/jcem.83.2.4529","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7_CR121","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1687-9856-2012-25","volume":"2012","author":"RK Shankar","year":"2012","unstructured":"Shankar RK, Rutter MJ, Chernausek SD, Samuels PJ, Mo JQ, Rutter MM (2012) Medullary thyroid cancer in a 9-week-old infant with familial MEN 2B: implications for timing of prophylactic thyroidectomy. Int J Pediatr Endocrinol 2012(1):25. https:\/\/doi.org\/10.1186\/1687-9856-2012-25","journal-title":"Int J Pediatr Endocrinol"},{"issue":"10","key":"7_CR122","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","volume":"15","author":"DP Smith","year":"1997","unstructured":"Smith DP, Houghton C, Ponder BA (1997) Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 15(10):1213\u20131217. https:\/\/doi.org\/10.1038\/sj.onc.1201481","journal-title":"Oncogene"},{"issue":"3","key":"7_CR123","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cen.12513","volume":"81","author":"D Taieb","year":"2014","unstructured":"Taieb D, Kebebew E, Castinetti F, Chen CC, Henry JF, Pacak K (2014) Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions. Clin Endocrinol 81(3):317\u2013328. https:\/\/doi.org\/10.1111\/cen.12513","journal-title":"Clin Endocrinol"},{"issue":"6","key":"7_CR124","first-page":"509","volume":"243","author":"M Takahashi","year":"1998","unstructured":"Takahashi M, Asai N, Iwashita T, Murakami H, Ito S (1998) Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations. J Intern Med 243(6):509\u2013513. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9681851","journal-title":"J Intern Med"},{"issue":"11","key":"7_CR125","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","volume":"98","author":"S Thosani","year":"2013","unstructured":"Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF et al (2013) The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 98(11):E1813\u2013E1819. https:\/\/doi.org\/10.1210\/jc.2013-1653","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7_CR126","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1530\/ERC-14-0491","volume":"22","author":"RA Toledo","year":"2015","unstructured":"Toledo RA, Hatakana R, Lourenco DM Jr, Lindsey SC, Camacho CP, Almeida M et al (2015) Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocr Relat Cancer 22(1):65\u201376. https:\/\/doi.org\/10.1530\/ERC-14-0491","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"7_CR127","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12020-009-9242-7","volume":"36","author":"E Vaclavikova","year":"2009","unstructured":"Vaclavikova E, Dvorakova S, Sykorova V, Bilek R, Dvorakova K, Vlcek P et al (2009) RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. Endocrine 36(3):419\u2013424. https:\/\/doi.org\/10.1007\/s12020-009-9242-7","journal-title":"Endocrine"},{"issue":"3","key":"7_CR128","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12020-021-02607-2","volume":"72","author":"MFM van den Broek","year":"2021","unstructured":"van den Broek MFM, Rijks EBG, Nikkels PGJ, Wolters VM, van Es RJJ, van Santen HM et al (2021) Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series. Endocrine 72(3):905\u2013914. https:\/\/doi.org\/10.1007\/s12020-021-02607-2","journal-title":"Endocrine"},{"issue":"2","key":"7_CR129","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1365-2265.2003.01782.x","volume":"59","author":"U Verga","year":"2003","unstructured":"Verga U, Fugazzola L, Cambiaghi S, Pritelli C, Alessi E, Cortelazzi D et al (2003) Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol 59(2):156\u2013161. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12864791","journal-title":"Clin Endocrinol"},{"issue":"8","key":"7_CR130","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2017-00317","volume":"102","author":"RK Voss","year":"2017","unstructured":"Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM et al (2017) Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness. J Clin Endocrinol Metab 102(8):2807\u20132813. https:\/\/doi.org\/10.1210\/jc.2017-00317","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"7_CR131","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells Jr","year":"2013","unstructured":"Wells SA Jr, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98(8):3149\u20133164. https:\/\/doi.org\/10.1210\/jc.2013-1204","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7_CR132","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6):567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"7_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.572151","volume":"11","author":"A Wurgler Hansen","year":"2020","unstructured":"Wurgler Hansen A, Sonderberg Roos LK, Lossl K, Godballe C, Mathiesen JS (2020) Preimplantation genetic testing of multiple endocrine neoplasia type 2A. Front Endocrinol (Lausanne) 11:572151. https:\/\/doi.org\/10.3389\/fendo.2020.572151","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"7_CR134","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","volume":"3","author":"J Zedenius","year":"1994","unstructured":"Zedenius J, Wallin G, Hamberger B, Nordenskjold M, Weber G, Larsson C (1994) Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet 3(8):1259\u20131262. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7987299","journal-title":"Hum Mol Genet"},{"issue":"5","key":"7_CR135","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1530\/EJE-08-0854","volume":"160","author":"D Zenaty","year":"2009","unstructured":"Zenaty D, Aigrain Y, Peuchmaur M, Philippe-Chomette P, Baumann C, Cornelis F et al (2009) Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. Eur J Endocrinol 160(5):807\u2013813. https:\/\/doi.org\/10.1530\/EJE-08-0854","journal-title":"Eur J Endocrinol"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-80396-3_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:00:14Z","timestamp":1742356814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-80396-3_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031803956","9783031803963"],"references-count":135,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-80396-3_7","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"20 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}